These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 4095270)

  • 21. Hürthle cell carcinoma: a clinicopathological study of thirteen cases.
    Ozlem Küçük N; Kulak H; Tokmak E; Tar P; Ibiş E; Aras G
    Nucl Med Commun; 2006 Apr; 27(4):377-9. PubMed ID: 16531925
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ablation of the thyroid remnant and 131I dose in differentiated thyroid cancer.
    Doi SA; Woodhouse NJ
    Clin Endocrinol (Oxf); 2000 Jun; 52(6):765-73. PubMed ID: 10848882
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Irradiating the thyroid. How to protect yourself and others.
    Jankowski CB
    Am J Nurs; 1996 Oct; 96(10):50-4. PubMed ID: 8863650
    [No Abstract]   [Full Text] [Related]  

  • 24. Iodine biokinetics and dosimetry in radioiodine therapy of thyroid cancer: procedures and results of a prospective international controlled study of ablation after rhTSH or hormone withdrawal.
    Hänscheid H; Lassmann M; Luster M; Thomas SR; Pacini F; Ceccarelli C; Ladenson PW; Wahl RL; Schlumberger M; Ricard M; Driedger A; Kloos RT; Sherman SI; Haugen BR; Carriere V; Corone C; Reiners C
    J Nucl Med; 2006 Apr; 47(4):648-54. PubMed ID: 16595499
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Thyroid cancer in infants and adolescents after Chernobyl.
    Reiners C; Demidchik YE; Drozd VM; Biko J
    Minerva Endocrinol; 2008 Dec; 33(4):381-95. PubMed ID: 18923372
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Effect of the plan of therapy on prognosis in thyroid cancer].
    Schümichen C; Schmitt E; Scheuffele C; Blattmann H; Pauli-Harnasch C
    Nuklearmedizin; 1983 Apr; 22(2):97-105. PubMed ID: 6866782
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Radioiodine and thyroid carcinoma].
    Valdés M; Pineda G
    Rev Med Chil; 1977 Sep; 105(9):603-8. PubMed ID: 757828
    [No Abstract]   [Full Text] [Related]  

  • 28. Differentiated thyroid carcinoma (DTC) in the elderly: disease outcome, therapeutic approach, and long-term results in a group of 314 patients.
    Girelli ME; Casara D; Rubello D; Mazzarotto R; Saladini G; Busnardo B
    J Endocrinol Invest; 1999; 22(10 Suppl):45-6. PubMed ID: 10727040
    [No Abstract]   [Full Text] [Related]  

  • 29. [Treatment of well-differentiated thyroid cancer].
    Roisman I; Lifshitz I; Sapir D; Bitterman A; Toledano H; Durst AL
    Harefuah; 1995 Mar; 128(6):340-8, 400. PubMed ID: 7750812
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Complications, sequela and dosimetry of iodine-131 therapy for thyroid carcinoma.
    Bushnell DL; Boles MA; Kaufman GE; Wadas MA; Barnes WE
    J Nucl Med; 1992 Dec; 33(12):2214-21. PubMed ID: 1460519
    [No Abstract]   [Full Text] [Related]  

  • 31. Selective use of radioactive iodine in the postoperative management of patients with papillary and follicular thyroid carcinoma.
    Hay ID
    J Surg Oncol; 2006 Dec; 94(8):692-700. PubMed ID: 17131429
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Radioiodine treatment for malignant thyroid disease.
    Berg G
    Acta Oncol; 2006; 45(8):1041-5. PubMed ID: 17118836
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Radioiodine therapy for thyroid cancer.
    Sweeney DC; Johnston GS
    Endocrinol Metab Clin North Am; 1995 Dec; 24(4):803-39. PubMed ID: 8608780
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Thyroperoxidase: a tumor marker for post-therapeutic follow-up of differentiated thyroid carcinomas? Results of a time course study.
    Franke WG; Zöphel K; Wunderlich GR; Mat R; Kühne A; Schimming C; Kropp J; Bredow J
    Cancer Detect Prev; 2000; 24(6):524-30. PubMed ID: 11198265
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Juvenile differentiated thyroid carcinoma and the role of radioiodine in its treatment: a qualitative review.
    Jarzab B; Handkiewicz-Junak D; Wloch J
    Endocr Relat Cancer; 2005 Dec; 12(4):773-803. PubMed ID: 16322322
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Late solitary thyroid carcinoma metastasis to the kidney: a case report.
    Matei DV; Verweij F; Scardino E; Rocco B; Renne G; Tradati N; De Cobelli O
    Anticancer Res; 2003; 23(1B):561-4. PubMed ID: 12680146
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The role of total thyroidectomy in the management of differentiated thyroid cancer.
    Stephenson BM; Wheeler MH; Clark OH
    Curr Opin Gen Surg; 1994; ():53-9. PubMed ID: 7584009
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Is radioiodine ablation of residual thyroid tissue indicated after an operation for differentiated thyroid cancer?].
    Chebotareva ED; Shishkina VV
    Lik Sprava; 1997; (1):118-22. PubMed ID: 9221132
    [No Abstract]   [Full Text] [Related]  

  • 39. Total thyroidectomy and adjuvant radioiodine treatment independently decrease locoregional recurrence risk in childhood and adolescent differentiated thyroid cancer.
    Handkiewicz-Junak D; Wloch J; Roskosz J; Krajewska J; Kropinska A; Pomorski L; Kukulska A; Prokurat A; Wygoda Z; Jarzab B
    J Nucl Med; 2007 Jun; 48(6):879-88. PubMed ID: 17536106
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Follow-up of differentiated thyroid carcinoma.
    Pagano L; Klain M; Pulcrano M; Angellotti G; Pasano F; Salvatore M; Lombardi G; Biondi B
    Minerva Endocrinol; 2004 Dec; 29(4):161-74. PubMed ID: 15765026
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.